Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3034552	li-ada	— (—)	189	195	100.00%	Distribution not available
3034552	li-ada	u/l (u/l)	51	58	6.90%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Neurological diseases

9.32

42.33

1.1

1.0

4.28

2.41

u/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

112

5.99

38.24

1.0

1.1

2.67

3.18

u/l

0.16

Other symptoms and signs involving the nervous and musculoskeletal systems

7.12

36.33

1.0

1.1

1.96

3.81

u/l

—

Headache

6.30

35.77

1.1

1.0

2.48

2.04

u/l

—

General symptoms and signs

4.45

27.08

1.1

1.0

3.36

2.67

u/l

0.20

Primary_lymphoid and hematopoietic malignant neoplasms

7.95

19.98

1.1

5.42

2.02

u/l

—

Fever of other and unknown origin

5.06

19.65

1.1

1.0

3.48

2.74

u/l

0.16

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

113

4.10

18.18

1.1

1.0

2.57

3.04

u/l

0.15

Other neurological diseases

122

3.76

17.66

1.1

1.0

3.12

3.11

u/l

0.00

Diagnoses used for exclusion with ILD

6.32

17.52

1.2

1.1

1.87

4.54

u/l

0.60

Primary_lymphoid and hematopoietic malignant neoplasms

6.60

17.00

1.1

5.42

1.74

u/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

145

3.29

16.64

1.0

1.1

2.65

3.34

u/l

0.25

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

150

3.25

16.47

1.1

1.0

2.14

3.65

u/l

0.69

Other symptoms and signs involving cognitive functions and awareness

4.91

15.91

1.0

1.1

2.50

3.88

u/l

—

Nerve, nerve root and plexus disorders

152

3.06

15.64

1.0

1.1

1.88

3.25

u/l

0.74

Encephalitis

26.73

15.62

1.1

1.0

1.98

—

u/l

—

Bacterial Sepsis

4.87

15.51

1.1

1.0

4.87

2.88

u/l

—

Oral corticosteroids

146

3.03

15.00

1.1

3.34

2.52

u/l

0.25

Bacterial infection, other or unspecified

4.03

14.87

1.2

1.0

3.79

2.59

u/l

0.27

Certain disorders involving the immune mechanism

6.11

14.64

1.2

1.0

1.92

5.33

u/l

—

Visual disturbances and blindness

4.07

14.39

1.1

2.50

3.14

u/l

—

Sarcoidosis

7.43

13.97

1.3

1.1

1.98

5.95

u/l

—

Malaise and fatigue

4.75

13.91

1.1

1.0

2.42

u/l

—

Implicit bacterial Sepsis

4.92

13.60

1.2

1.0

5.14

2.88

u/l

—

Non-follicular lymphoma, hilmo, excluding all cancers

11.71

13.53

1.1

1.0

6.18

—

u/l

—

Visual disturbances

4.10

13.43

1.0

1.1

2.74

3.31

u/l

—

Cerebrovascular diseases (FINNGEN)

5.47

13.38

1.1

2.43

6.10

u/l

—

Inflammatory bowel disease treatment related agents

154

2.77

13.03

1.1

3.49

2.37

u/l

0.39

ILD medications

144

2.78

12.68

1.1

1.0

3.26

2.55

u/l

0.20

Other bacterial diseases

143

2.95

12.59

1.1

1.0

3.63

2.65

u/l

0.23

Epilepsy

5.20

12.41

1.1

1.57

2.62

u/l

—

ILD medications: immunosuppressive drugs

125

3.38

12.37

1.1

1.0

2.02

2.35

u/l

0.23

ILD medications: prednisolone, methylprednisolone, prednisone

140

2.79

12.14

1.1

3.34

2.61

u/l

0.22

GASTRO-related operations

3.33

11.85

1.1

1.0

2.30

4.10

u/l

0.36

Any gastric operation

3.33

11.85

1.1

1.0

2.30

4.10

u/l

0.36

First line medication for Crohn's disease

143

2.67

11.32

1.1

1.0

3.73

2.24

u/l

0.53

Any reimbursement code in KELA

3.58

11.15

1.1

1.0

5.01

2.30

u/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

139

2.65

10.60

1.1

1.0

2.49

3.18

u/l

0.24

Other special examinations and investigations of persons without complaint or reported diagnosis

3.40

10.46

1.1

1.58

4.40

u/l

—

Autoimmune diseases excluding thyroid diseases

143

2.60

10.41

1.1

1.0

2.49

3.18

u/l

0.24

Polyneuropathies and other disorders of the peripheral nervous system

5.01

10.03

1.0

1.1

2.37

4.66

u/l

—

General examination and investigation of persons without complaint and reported diagnosis

3.34

9.72

1.0

1.1

2.70

4.40

u/l

—

Persons encountering health services for specific procedures and health care

159

2.49

9.50

1.1

4.89

2.29

u/l

0.59

Implicit Sepsis

118

2.90

9.22

1.1

1.0

3.99

2.87

u/l

0.23

Condition for Implicit Sepsis (Organ dysfunction codes)

131

2.66

8.50

1.1

1.0

3.69

2.81

u/l

0.16

Migraine

3.24

8.28

1.1

1.0

2.98

2.11

u/l

—

Systemic connective tissue disorders

3.68

8.15

1.0

1.1

2.25

4.14

u/l

—

Cardiovascular diseases (excluding rheumatic etc)

2.89

8.06

1.1

2.96

3.81

u/l

—

Hypotension

5.84

7.84

1.0

1.1

2.32

6.02

u/l

—

Symptoms and signs involving the digestive system and abdomen

113

2.48

7.81

1.1

2.54

3.45

u/l

0.33

Episodal and paroxysmal disorders

135

2.35

7.81

1.1

4.25

2.63

u/l

—

Dorsalgia

131

2.40

7.73

1.1

1.70

3.00

u/l

—

Pain (limb, back, neck, head abdominally)

2.85

7.37

1.1

1.44

4.04

u/l

—

Nausea and vomiting

4.32

7.23

1.1

1.0

3.46

4.99

u/l

—

Other CVD

5.01

7.17

1.0

1.1

2.32

5.33

u/l

—

Diseases of the eye and adnexa

100

2.51

7.13

1.1

2.38

3.56

u/l

—

Persons encountering health services for examination and investigation

2.84

6.82

1.1

1.75

4.40

u/l

—

Other and unspecified polyneuropathies, also in other diseases

4.45

6.70

1.1

2.37

4.66

u/l

—

Dizziness and giddiness

124

2.55

6.63

1.0

1.1

2.96

3.33

u/l

—

Influenza and pneumonia

171

2.19

6.62

1.1

2.57

3.12

u/l

0.23

Other dorsopathies, not elsewhere classified

131

2.26

6.55

1.0

1.1

2.24

3.00

u/l

0.31

Cerebrovascular diseases

113

2.54

6.51

1.1

2.06

3.25

u/l

—

Other functional intestinal disorders

2.99

6.37

1.0

1.1

2.14

3.66

u/l

—

Abdominal and pelvic pain

113

2.31

6.35

1.1

2.08

3.45

u/l

—

Other disorders of fluid, electrolyte and acid-base balance

3.74

6.32

1.2

1.1

1.57

4.07

u/l

—

Implicit fungal Sepsis

18.12

6.27

1.0

—

u/l

—

Bronchitis

176

2.12

6.16

1.0

1.1

2.52

2.92

u/l

—

Low back pain

127

2.43

6.08

1.1

3.10

3.13

u/l

—

Autoimmune diseases related-to ILD

181

2.24

6.00

1.1

1.77

3.21

u/l

1.02

Fungal Sepsis

15.08

5.90

1.0

—

u/l

—

Constipation

144

2.24

5.66

1.1

1.66

3.41

u/l

—

Autoimmune diseases

143

2.07

5.56

1.1

1.0

2.65

3.18

u/l

0.18

Other and unspecified anaemias

3.09

5.52

1.1

1.0

1.43

4.03

u/l

—

Other anaemias

3.08

5.49

1.1

1.0

1.43

4.03

u/l

—

All influenza

3.62

5.47

1.0

1.1

3.34

4.62

u/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

171

2.10

5.46

1.1

2.39

3.25

u/l

—

Medical observation and evaluation for suspected diseases and conditions

2.60

5.33

1.1

2.25

4.40

u/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

132

2.18

5.31

1.1

2.53

3.31

u/l

—

132

2.18

5.31

1.1

2.53

3.31

u/l

—

STROKE

2.52

5.31

1.0

1.1

2.29

3.64

u/l

—

Lumbar disc prolapse

111

2.44

5.29

1.0

1.1

2.18

3.28

u/l

—

Other intervertebral disc disorders

121

2.23

5.28

1.0

1.1

2.89

3.20

u/l

—

Disorders of other endocrine glands

2.77

5.22

1.2

1.1

1.59

3.69

u/l

—

Second line medication for Crohn's disease

138

2.39

5.19

1.1

1.89

3.32

u/l

—

Used for control exclusion in common control thyroid runs

133

2.06

5.11

1.1

1.0

2.83

3.32

u/l

0.15

Certain infectious and parasitic diseases

108

2.18

5.09

1.1

1.0

4.38

2.51

u/l

0.43

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2.97

5.09

1.1

1.0

1.94

2.19

u/l

—

Hypo-osmolality and hyponatraemia

4.19

5.06

1.2

1.1

1.44

4.95

u/l

—

Excluding asthma or asthma-COPD overlap

2.33

5.03

1.1

2.02

4.56

u/l

—

L04AX Other immunosuppressants

134

2.39

5.03

1.1

1.89

3.32

u/l

—

Carpal tunnel syndrome

104

2.52

4.98

1.0

1.1

2.48

3.43

u/l

—

Pneumonias (Asthma/COPD co-morbidities)

175

2.02

4.98

1.1

2.39

3.18

u/l

—

Psychiatric diseases

147

1.98

4.93

1.1

2.36

2.87

u/l

—

External causes of morbidity and mortality

2.30

4.92

1.1

2.73

3.17

u/l

—

Diseases of oesophagus, stomach and duodenum

165

1.99

4.91

1.1

1.81

3.26

u/l

—

All pneumoniae

176

2.00

4.86

1.1

2.39

3.18

u/l

—

Acute renal failure

3.69

4.64

1.1

6.60

2.09

u/l

—

Aplastic and other anaemias

2.78

4.64

1.1

1.0

1.43

4.03

u/l

—

Other antidepressants

143

1.97

4.63

1.1

1.69

2.92

u/l

—

Stroke, excluding SAH

2.40

4.49

1.0

1.1

2.36

3.54

u/l

—

Ischaemic Stroke, excluding all haemorrhages

2.46

4.45

1.0

1.1

2.72

3.43

u/l

—

COPD/asthma related infections

132

1.97

4.44

1.1

2.23

3.31

u/l

—

COPD/asthma/ILD related infections

132

1.97

4.44

1.1

2.23

3.31

u/l

—

Cardiovascular diseases

2.37

4.43

1.1

1.78

3.74

u/l

—

155

1.91

4.42

1.0

1.1

2.19

3.17

u/l

—

Pneumonia, organism unspecified

158

2.01

4.35

1.1

2.23

3.19

u/l

—

Migraine with aura

3.50

4.32

1.0

1.1

—

3.20

—

Other pulmonary diagnosis

2.21

4.32

1.1

2.07

4.56

u/l

—

Focal epilepsy

3.34

4.31

1.1

1.64

5.20

u/l

—

Diseases of the musculoskeletal system and connective tissue

2.43

4.30

1.1

5.82

2.75

u/l

—

Cardiac arrhythmias

2.27

4.29

1.0

1.39

3.44

u/l

—

Other systemic involvement of connective tissue (FG)

3.18

4.27

1.1

1.0

1.70

5.44

u/l

—

Genitourinary diseases

2.28

4.25

1.1

4.91

1.60

u/l

—

Gastrointestinal diseases

2.28

4.25

1.1

1.0

1.62

4.10

u/l

—

Stroke, including SAH

101

2.27

4.15

1.0

1.1

2.36

3.69

u/l

—

Metabolic disorders

142

1.97

4.07

1.1

1.0

2.23

3.16

u/l

—

Myalgia

3.13

3.92

1.2

1.1

1.82

5.00

u/l

—

Malignant neoplasm

125

1.99

3.90

1.1

1.0

4.37

2.10

u/l

0.49

COPD differential diagnosis

2.13

3.88

1.1

2.02

4.56

u/l

—

ILD differential diagnosis

2.13

3.88

1.1

2.02

4.56

u/l

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

126

1.97

3.79

1.1

1.0

4.21

2.15

u/l

0.48

Acute upper respiratory infections of multiple and unspecified sites

142

2.01

3.79

1.0

1.1

2.34

2.80

u/l

—

Malignant neoplasm, wide definition for exclusion

126

1.97

3.79

1.1

1.0

4.21

2.16

u/l

0.48

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

126

1.97

3.79

1.1

1.0

4.21

2.16

u/l

0.48

Exclusions for E4_PCOS_BROAD

3.18

3.76

1.2

1.1

1.61

5.27

u/l

—

Lower back pain or/and sciatica

185

1.84

3.74

1.0

1.1

2.83

2.84

u/l

—

Other systemic involvement of connective tissue

2.91

3.73

1.1

1.70

4.29

u/l

—

Any mental disorder

157

1.79

3.64

1.1

2.65

2.92

u/l

—

Examination and observation for other reasons

2.36

3.63

1.1

2.42

4.40

u/l

—

Codes for special purposes

2.37

3.63

1.1

2.05

3.51

u/l

—

Provisional assignment of new diseases of uncertain etiology

2.37

3.63

1.1

2.05

3.52

u/l

—

Dermatitis

142

2.11

3.63

1.1

1.0

1.59

3.28

u/l

—

Spondylopathies

107

2.04

3.61

1.1

3.13

3.36

u/l

—

Diseases of the skin and subcutaneous tissue

138

1.82

3.45

1.1

1.0

3.59

2.60

u/l

0.24

Complications of medical and surgical care

163

1.98

3.45

1.1

2.68

3.02

u/l

0.13

Intestinal infectious diseases

188

1.82

3.38

1.1

1.98

2.86

u/l

—

Dental caries, including avohilmo

2.00

3.30

1.0

1.1

2.86

3.52

u/l

—

Dental caries 1

2.00

3.30

1.0

1.1

2.86

3.52

u/l

—

Hypertension, essential

112

1.94

3.28

1.1

2.66

3.38

u/l

—

Other external causes of accidental injury

115

1.87

3.27

1.0

1.1

1.61

3.43

u/l

—

Hard cardiovascular diseases

114

1.97

3.26

1.1

2.50

3.46

u/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

153

1.96

3.25

1.1

2.05

2.83

u/l

—

Renal failure

2.41

3.23

1.1

6.60

2.37

u/l

—

Pain in throat and chest

139

1.85

3.22

1.0

1.1

2.38

2.96

u/l

—

Fall on same level

180

1.71

3.20

1.0

1.1

1.83

3.04

u/l

—

Dental caries 1, only avohilmo

1.95

3.18

1.0

1.1

2.86

3.47

u/l

—

Disorders of skin appendages

110

2.18

3.17

1.0

1.1

3.16

3.24

u/l

—

Chronic lower respiratory diseases

179

1.69

3.15

1.0

1.1

2.47

2.89

u/l

—

L04AA Selective immunosuppressants

2.73

3.15

1.1

2.18

4.75

u/l

—

Other soft tissue disorders, not elsewhere classified

147

1.81

3.10

1.1

2.21

3.22

u/l

—

Acute upper respiratory infections

169

1.74

3.03

1.0

1.1

2.44

2.79

u/l

—

Accidents

115

1.83

3.01

1.0

1.1

1.61

3.43

u/l

—

Parasetamol

110

1.86

3.00

1.1

2.34

3.67

u/l

—

Appendectomy

161

1.91

3.00

1.1

1.40

3.08

u/l

—

Other diseases of blood and blood-forming organs, wide

2.75

2.98

1.2

1.1

1.38

5.54

u/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

3.00

2.96

1.2

1.1

1.64

5.80

u/l

—

Diseases of the respiratory system

2.00

2.96

1.1

2.43

3.93

u/l

—

Pain in joint

2.21

2.89

1.0

1.1

1.55

4.04

u/l

—

Renal tubulo-interstitial diseases

162

1.80

2.85

1.1

5.58

2.57

u/l

—

Complications of surgical and medical care, not elsewhere classified

178

1.73

2.82

1.1

2.93

2.91

u/l

0.01

Dorsopathies

132

1.74

2.78

1.0

1.1

2.30

3.00

u/l

—

Neoplasms

104

1.86

2.76

1.1

6.16

1.98

u/l

—

Benign neoplasm: Adrenal gland

6.01

2.70

1.0

—

Temporomandibular joint disorders

3.75

2.67

1.0

1.1

—

8.46

—

Other and unspecified dermatitis

112

2.05

2.66

1.1

1.0

1.59

3.42

u/l

—

Injuries to the ankle and foot

159

1.83

2.65

1.0

1.1

1.72

2.99

u/l

—

Any event in cancer register

140

1.74

2.63

1.1

4.71

2.42

u/l

—

Reimbursement for rheumatic diseases

133

1.95

2.62

1.1

1.0

2.66

2.96

u/l

—

Melanocytic naevi

2.55

2.61

1.1

1.0

1.40

3.09

u/l

—

Anxiety disorders, excluding more controls

144

1.75

2.56

1.1

3.17

2.65

u/l

—

Dental caries 1 and operation codes

111

1.76

2.46

1.0

1.1

2.86

3.30

u/l

—

Glaucoma suspect

2.24

2.43

1.1

2.42

3.59

u/l

—

Abnormal findings on examination of blood, without diagnosis

102

2.02

2.42

1.2

1.0

2.61

3.90

u/l

—

Benzodiazepine use

186

1.65

2.39

1.1

1.28

3.07

u/l

—

Carrier of infectious disease

6.28

2.37

1.4

1.0

—

Disorders of vestibular function (Vertigo)

2.07

2.28

1.0

1.1

2.98

3.40

u/l

—

Diseases of inner ear

110

1.96

2.27

1.0

1.1

2.98

2.92

u/l

—

Covid-19 confirmed case

2.27

2.24

1.1

2.58

4.96

u/l

—

Pain in limb

138

1.73

2.22

1.0

1.1

2.57

3.51

u/l

—

Dyspnoea

164

1.68

2.22

1.1

2.79

3.06

u/l

—

Asthma/COPD (KELA code 203)

179

1.61

2.15

1.0

1.1

1.72

2.89

u/l

—

Presence of other functional implants

1.92

2.12

1.1

2.25

3.32

u/l

—

Oxycodone

2.15

2.10

1.0

1.1

—

3.77

u/l

—

Diseases of the digestive system

2.00

2.08

1.1

3.43

3.08

u/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

145

1.79

2.07

1.1

3.07

3.05

u/l

—

Disorders of lens

104

1.76

2.03

1.1

2.20

3.31

u/l

—

Other diseases of intestines

167

1.57

2.03

1.0

1.1

1.75

3.21

u/l

—

Urticaria and erythema

2.00

1.99

1.1

1.50

3.58

u/l

—

Senile cataract

1.81

1.99

1.1

2.26

3.82

u/l

—

Benign neoplasms

106

1.71

1.99

1.1

2.92

1.98

u/l

—

Finngen Rheumatological endpoints

151

1.59

1.99

1.1

2.97

3.44

u/l

—

Use of hypnotics and sedatives

167

1.56

1.99

1.0

1.1

1.35

3.33

u/l

—

Heart failure, not strict

126

1.70

1.96

1.1

1.28

3.45

u/l

—

Dental pulpitis 1

154

1.55

1.95

1.0

1.1

1.22

3.16

u/l

—

Diseases of pulp and periapical tissues, including avohilmo

154

1.55

1.95

1.0

1.1

1.22

3.16

u/l

—

Dental pulpitis 4

154

1.55

1.95

1.0

1.1

1.22

3.16

u/l

—

Neurotic, stress-related and somatoform disorders

169

1.60

1.94

1.1

1.0

3.17

2.66

u/l

—

Dermatitis and eczema

192

1.54

1.93

1.1

1.73

3.09

u/l

—

Other disorders of skin and subcutaneous tissue

143

1.73

1.92

1.1

1.0

4.60

2.30

u/l

—

Shoulder lesions

117

1.67

1.90

1.1

2.16

3.61

u/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

135

1.78

1.90

1.1

1.0

2.66

2.92

u/l

—

Other disorders of urethra and urinary system

122

1.72

1.90

1.1

1.0

4.22

2.69

u/l

—

Viral infections characterized by skin and mucous membrane lesions

1.92

1.89

1.0

1.1

1.85

3.44

u/l

—

Abnormalities of breathing

146

1.59

1.88

1.0

1.1

2.36

2.79

u/l

—

Anxiety disorders

170

1.58

1.88

1.1

1.0

3.17

2.66

u/l

—

Symptoms and signs involving the urinary system

144

1.66

1.88

1.1

4.16

2.95

u/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

163

1.58

1.87

1.1

2.56

3.15

u/l

0.21

Pulmonary heart disease, diseases of pulmonary circulation

2.20

1.83

1.2

1.1

2.96

4.40

u/l

—

Opioids

146

1.55

1.82

1.0

1.1

2.63

2.87

u/l

—

Depression

178

1.55

1.80

1.1

4.24

2.59

u/l

—

Codeine

142

1.55

1.73

1.0

1.1

2.61

2.87

u/l

—

Other diseases of upper respiratory tract

164

1.49

1.73

1.0

1.1

2.03

2.99

u/l

—

Acute appendicitis

175

1.62

1.71

1.1

1.20

3.07

u/l

—

Disorders of eyelid, lacrimal system and orbit

163

1.59

1.70

1.0

1.1

2.80

3.14

u/l

—

Other medical care

1.95

1.68

1.1

1.0

6.23

2.16

u/l

—

Hypertensive diseases

117

1.60

1.65

1.1

2.66

3.21

u/l

—

Hypertension

117

1.60

1.64

1.1

2.66

3.21

u/l

—

Mood [affective] disorders

186

1.49

1.59

1.1

4.24

2.55

u/l

—

Melanocytic naevi

2.00

1.58

1.1

1.0

1.40

4.82

u/l

—

Other diseases of urinary system

155

1.49

1.53

1.1

1.0

4.63

2.31

u/l

0.69

Glaucoma

107

1.72

1.51

1.1

1.0

2.13

3.16

u/l

—

Other heart diseases, wide

162

1.49

1.51

1.1

1.38

3.58

u/l

—

Ocular pain

2.86

1.50

1.0

—

7.30

—

Paroxysmal tachycardia

2.45

1.48

1.0

—

7.32

—

DVT of lower extremities and pulmonary embolism

1.89

1.47

1.1

3.20

3.66

u/l

—

Other arrhythmias

129

1.60

1.47

1.1

1.43

4.19

u/l

—

Unspecified mental disorder

102

1.76

1.44

1.1

—

3.36

—

Pregnancy with abortive outcome

1.62

1.44

1.1

1.0

2.87

3.56

u/l

—

Statin medication

116

1.55

1.43

1.2

1.1

4.32

3.41

u/l

—

Venous thromboembolism

114

1.70

1.42

1.1

3.20

3.34

u/l

—

Type 2 diabetes, wide definition

131

1.54

1.42

1.2

1.0

3.42

3.23

u/l

—

Excessive vomiting in pregnancy

2.61

1.36

1.0

1.1

—

5.90

—

Appendicitis, broad definition

181

1.52

1.35

1.1

1.20

3.07

u/l

—

Polyarthropathies

120

1.56

1.34

1.1

2.34

3.91

u/l

—

Rotator cuff syndrome

105

1.63

1.34

1.0

1.1

2.62

3.80

u/l

—

Unspecified lump in breast

0.00

1.33

0.0

1.0

—

4.93

—

Diseases of appendix

183

1.49

1.28

1.1

1.20

3.07

u/l

—

Dental pulpitis 4, only avohilmo

163

1.41

1.27

1.0

1.1

1.22

3.06

u/l

—

Migraine with aura and triptan purchases

2.29

1.26

1.0

1.1

—

5.02

—

Dental pulpitis 1, only avohilmo

164

1.40

1.24

1.0

1.1

1.22

3.06

u/l

—

Presence of other devices

2.22

1.24

1.1

—

4.52

—

Pulmonary embolism

1.96

1.21

1.2

1.1

3.20

4.40

u/l

—

Pulmonary heart disease

1.96

1.21

1.2

1.1

3.20

4.40

u/l

—

Other arthrosis

1.62

1.20

1.0

1.1

1.97

4.13

u/l

—

Family history of malignant neoplasm

0.00

1.16

0.0

1.1

—

5.56

—

Diseases of the ear and mastoid process

175

1.36

1.13

1.0

1.1

2.16

3.05

u/l

—

Falls/tendency to fall

162

1.36

1.07

1.0

1.1

1.89

3.10

u/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.76

1.06

1.1

2.52

3.75

u/l

—

Benign neoplasm of other and unspecified endocrine glands

2.12

1.05

1.0

1.1

—

5.27

—

Dentofacial anomalies [including malocclusion]

1.80

1.05

1.0

1.1

—

3.89

—

Other disorders of ear

156

1.41

1.04

1.0

1.1

2.04

3.35

u/l

—

Other condition

2.06

1.02

1.0

1.1

—

6.58

u/l

—

Candidiasis

2.00

1.00

1.0

1.1

—

4.99

u/l

—

Polycystic ovarian syndrome, consortium definition

107

1.47

0.99

1.0

1.1

3.41

2.84

u/l

—

Gout, strict definition

0.00

0.97

0.0

1.1

—

5.77

—

Monoamine oxidase A inhibitors

0.00

0.97

0.0

1.1

—

4.74

—

Extrapyramidal and movement disorders

1.74

0.96

1.1

—

3.56

—

Osteopathies and chondropathies

118

1.53

0.94

1.1

6.25

2.03

u/l

—

Codeine or tramadol medication

180

1.32

0.93

1.0

1.1

2.86

2.73

u/l

—

Endocrine, nutritional and metabolic diseases

117

1.39

0.92

1.2

1.0

3.64

3.24

u/l

—

Diverticular disease of intestine

104

1.47

0.91

1.0

1.1

1.43

3.50

u/l

—

Complications of procedures, not elsewhere classified

173

1.40

0.91

1.1

2.79

2.97

u/l

—

Soft tissue disorders

147

1.34

0.90

1.1

2.40

3.22

u/l

—

Injuries to the knee and lower leg

193

1.30

0.88

1.0

1.1

2.21

3.01

u/l

—

Degenerative diseases of the nervous system

1.88

0.88

1.0

1.1

—

4.04

—

Symptoms and signs involving the circulatory and respiratory systems

147

1.33

0.87

1.1

2.97

2.79

u/l

—

Panic disorder

1.82

0.85

1.3

1.1

—

5.17

u/l

—

Benign neoplasms

151

1.33

0.83

1.1

2.73

2.98

u/l

—

Disorders of sclera, cornea, iris and ciliary body

129

1.47

0.83

1.1

1.70

3.35

u/l

—

Infections of the skin and subcutaneous tissue

145

1.44

0.83

1.1

2.28

3.07

u/l

—

Other specific joint derangements/joint disorders

137

1.37

0.80

1.0

1.1

1.55

3.32

u/l

—

Cystitis

130

1.36

0.79

1.1

1.0

3.56

2.61

u/l

—

Other disorders of eye and adnexa

1.82

0.79

1.0

1.1

—

5.56

—

Chalazion

0.00

0.79

0.0

1.2

—

6.32

—

Injury of muscle and tendon at hip and thigh level

0.00

0.78

0.0

1.1

—

7.30

—

Noninflammatory disorders of female genital tract

1.55

0.77

1.2

1.0

7.34

1.51

u/l

—

Adhesive capsulitis of shoulder

1.77

0.76

1.0

1.1

—

5.11

—

Superficial injury of shoulder and upper arm

0.00

0.76

0.0

1.1

—

7.70

—

Acute tubulo-interstitial nephritis

124

1.43

0.76

1.1

2.74

2.31

u/l

—

Iridocyclitis

1.70

0.75

1.1

1.54

4.56

u/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

164

1.31

0.72

1.1

2.57

3.12

u/l

—

Infective dermatitis

2.00

0.72

1.2

1.1

—

6.94

u/l

—

Diabetic nephropathy

1.97

0.72

1.0

1.2

—

2.51

—

Type 2 diabetes

166

1.29

0.70

1.2

1.0

2.81

2.89

u/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.85

0.68

1.0

—

6.13

—

Glomerular disorders in diseases classified elsewhere

1.85

0.68

1.0

1.1

—

6.58

—

Biological medication for rheuma

1.67

0.68

1.0

1.1

—

5.90

—

Spontaneous abortion

1.47

0.67

1.1

2.04

3.97

u/l

—

Diabetes, varying definitions

174

1.27

0.66

1.2

1.0

2.81

2.84

u/l

—

Diabetes mellitus

174

1.27

0.65

1.2

1.0

2.81

2.84

u/l

—

Hypothyroidism, strict autoimmune

112

1.36

0.65

1.1

1.0

2.68

3.49

u/l

—

Lichen planus, including avohilmo

1.59

0.65

1.1

—

4.60

u/l

—

Arthropathies

139

1.28

0.65

1.1

2.81

3.33

u/l

—

Diabetic nephropathy, excluding more controls

1.74

0.64

1.0

1.1

—

3.77

—

Lichen planus

1.72

0.64

1.2

1.1

—

4.74

u/l

—

Other skin changes

1.72

0.64

1.0

1.1

—

2.24

—

Malignant neoplasm of prostate

1.55

0.62

1.1

3.30

2.69

u/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.60

0.61

1.1

—

4.30

u/l

—

Other extrapyramidal and movement disorders in other diseases

1.60

0.61

1.0

1.1

—

4.25

—

Other joint disorders

138

1.27

0.60

1.0

1.1

2.11

3.33

u/l

—

Unspecified urinary incontinence

0.00

0.60

0.0

1.1

—

5.56

—

Glaucoma, exfoliation

0.00

0.59

0.0

1.1

—

5.30

—

Strabismus

1.56

0.58

1.2

1.1

—

4.03

—

Emotionally unstable personality disorder

1.72

0.57

1.2

1.1

—

5.92

—

Personality disorders, excluding more controls

1.48

0.57

1.1

—

4.95

—

Alzheimer disease

1.62

0.55

1.0

1.1

—

4.04

—

malignant neoplasm of male genital organs

1.49

0.55

1.1

3.30

2.69

u/l

—

Tumor necrosis factor alpha inhibitors

1.58

0.54

1.0

1.1

—

5.85

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.48

0.50

1.0

—

1.72

—

Alzheimer disease, including avohilmo

1.58

0.49

1.0

1.1

—

4.04

—

Gingivitis and periodontal diseases

129

1.24

0.48

1.1

1.77

3.01

u/l

—

Kela-code for severe mental illness

1.40

0.48

1.1

—

3.60

—

Persons encountering health services in other circumstances, wide

182

1.20

0.47

1.1

1.62

3.08

u/l

—

Conductive and sensorineural hearing loss

137

1.26

0.47

1.0

1.1

2.19

3.36

u/l

—

Supervision of normal pregnancy

1.43

0.46

1.0

—

2.68

—

Pre-eclampsia or poor fetal growth

0.61

0.45

1.2

1.0

—

3.85

—

Exclusions for E4_PCOS_CONSORTIUM

119

1.26

0.45

1.1

2.84

3.24

u/l

—

Injury of eye and orbit

1.61

0.43

1.0

1.1

—

5.72

—

Other metabolic disorders

1.52

0.41

1.0

—

4.95

—

Other obstetric trauma

0.00

0.41

0.0

1.0

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.0

—

Allergic contact dermatitis

1.47

0.40

1.2

1.1

—

5.20

—

Cardiomyopathy

1.47

0.40

1.0

1.1

—

4.43

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.33

0.40

1.0

1.1

—

4.22

—

Type 2 diabetes, definitions combined

159

1.20

0.40

1.2

1.0

2.81

2.95

u/l

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.39

0.0

1.2

—

6.28

—

Type 2 diabetes, strict (exclude DM1)

160

1.19

0.38

1.2

1.0

2.81

2.95

u/l

—

Irritable bowel syndrome

1.36

0.38

1.0

1.1

—

4.33

—

Diaphragmatic hernia

0.64

0.35

1.0

1.1

—

3.58

—

Persistent mood disorders

1.36

0.34

1.2

1.1

—

4.78

—

Nasal polyp

1.33

0.33

1.0

1.1

—

5.09

—

Degeneration of macula and posterior pole

0.69

0.33

1.0

1.1

—

3.57

—

Other disorders of patella

1.30

0.33

1.0

1.1

—

5.05

—

Bleeding

152

1.20

0.32

1.0

1.1

2.98

3.17

u/l

—

Other hearing loss

1.28

0.32

1.0

1.1

—

3.91

—

Diabetes, insulin treatment (Kela reimbursement)

181

0.84

0.31

1.2

1.0

2.74

3.03

u/l

—

Deforming dorsopathies

1.30

0.30

1.0

1.1

—

4.08

—

Disorders of the thyroid gland

175

1.16

0.29

1.1

2.49

2.81

u/l

—

Artrosis, including avohilmo

132

1.16

0.27

1.0

1.1

2.30

3.38

u/l

—

Gestational [pregnancy-induced] hypertension

1.23

0.27

1.0

1.1

—

4.22

u/l

—

Heart failure and bmi 25plus

0.69

0.26

1.0

1.1

—

2.76

u/l

—

Haemorrhage from respiratory passages

0.67

0.26

1.0

1.1

—

3.31

—

Diabetes medication

176

1.14

0.26

1.2

1.0

2.81

2.84

u/l

—

Diseases of oral cavity, salivary glands and jaws

129

1.15

0.25

1.1

3.00

3.01

u/l

—

Type 2 diabetes, definitions combined, including avohilmo

162

1.13

0.23

1.2

1.0

2.81

2.89

u/l

—

Congenital malformations of the circulatory system

1.24

0.22

1.0

1.1

—

5.87

—

Sensorineural hearing loss

133

1.16

0.22

1.0

1.1

2.19

3.36

u/l

—

Motorcycle rider injured in noncollision transport accidents

0.00

0.21

0.0

1.0

—

Ulcerative enterocolitis

0.00

0.21

0.0

1.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.21

0.0

1.0

—

Other orthopaedic follow-up care

0.00

0.21

0.0

1.0

—

Pyothorax

0.00

0.21

0.0

1.0

—

Early complications of trauma

0.00

0.21

0.0

1.0

—

!Aliquae complicationes praecoces traumatis

0.00

0.21

0.0

1.0

—

Contact with nonpowered hand tool

0.00

0.21

0.0

1.0

—

Convalescence

0.00

0.21

0.0

1.0

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Other (not insulin) diabetes medications

165

0.88

0.21

1.2

1.0

2.64

2.95

u/l

—

Schizophrenia

1.16

0.21

1.2

1.1

—

6.62

—

Nonorganic sleeping disorders, excluding more controls

1.16

0.21

1.0

1.1

—

4.48

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

156

1.14

0.21

1.1

2.44

2.96

u/l

—

Struck by thrown, projected or falling objec

0.00

0.21

0.0

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

0.21

0.0

1.1

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

1.25

0.20

1.0

1.1

—

4.79

u/l

—

Other and unspecified nonorganic psychotic disorders

1.22

0.20

1.2

1.1

—

5.29

—

Parodontitis and operation codes

179

1.13

0.19

1.1

2.54

3.05

u/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

103

1.19

0.19

1.0

1.1

—

3.40

u/l

—

Speech therapy

1.21

0.18

1.0

1.1

—

4.29

—

Diabetic retinopathy

0.72

0.17

1.0

1.2

—

3.14

—

Injuries to the neck

1.13

0.17

1.1

—

4.19

—

Sulfonylureas

0.71

0.17

1.0

1.1

—

3.77

—

Sub-endpoint used in defining T1D endpoints

0.74

0.17

1.2

1.1

—

3.91

—

Schizophrenia or delusion, excluding more controls

1.18

0.16

1.1

—

3.84

—

Specific personality disorders

1.18

0.16

1.1

—

4.70

—

Injuries to the shoulder and upper arm

180

1.12

0.16

1.0

1.1

1.97

3.24

u/l

—

Chronic periodontitis, including avohilmo

180

1.11

0.16

1.1

2.54

3.05

u/l

—

Parodontitis

180

1.11

0.15

1.1

2.54

3.05

u/l

—

Parodontitis or operation codes

180

1.10

0.15

1.1

2.54

3.05

u/l

—

Gonarthrosis

0.87

0.13

1.0

1.1

—

4.13

—

Myocardial infarction, strict

0.83

0.13

1.0

1.1

—

3.29

u/l

—

Coxarthrosis [arthrosis of hip](FG)

1.14

0.12

1.0

1.1

2.62

3.82

u/l

—

Arthrosis

110

1.10

0.11

1.0

1.1

2.52

3.78

u/l

—

Myocardial infarction

0.86

0.11

1.0

1.1

—

3.39

u/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

181

1.07

0.10

1.1

1.23

3.08

u/l

—

Cough

1.15

0.10

1.0

1.1

—

3.38

u/l

—

Erosion of teeth, including avohilmo

1.12

0.10

1.0

—

1.83

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.11

0.09

1.2

1.1

—

6.78

—

Ganglion

1.11

0.09

1.2

1.1

—

5.00

—

Hypertensive heart and/or renal disease

1.08

0.09

1.0

1.1

—

4.18

u/l

—

Hypothyroidism, other/unspecified

164

0.93

0.09

1.1

2.68

2.89

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.04

0.09

1.0

1.1

—

5.00

—

Chronic gastritis

1.04

0.09

1.0

1.1

—

4.59

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

164

0.93

0.09

1.2

1.0

2.74

2.87

u/l

—

Dysplasia of cervi uteri

1.10

0.09

1.0

—

1.63

—

Nonsuppurative otitis media

0.77

0.08

1.0

1.1

—

4.36

—

Colonic or urogenital fistula

0.78

0.08

1.0

1.1

—

4.08

—

Type 1 diabetes

0.78

0.08

1.2

1.0

—

3.86

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.83

0.07

1.0

1.1

—

4.26

—

Conjunctivitis (acute, non atopic)

0.81

0.07

1.0

1.1

—

4.07

—

Personality disorders

1.05

0.07

1.1

—

4.42

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.86

0.07

1.0

1.1

—

4.12

—

Coronary angioplasty

1.08

0.07

1.0

1.1

—

3.69

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.02

0.07

1.0

1.1

—

2.05

—

Dental caries 2, only avohilmo

171

1.06

0.06

1.2

1.1

1.90

2.96

u/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

174

0.95

0.05

1.1

2.68

2.83

u/l

—

Pregnancy hypertension

1.09

0.05

1.0

1.1

—

3.51

u/l

—

Exposure to unspecified factor

211

0.96

0.04

1.1

2.59

2.85

u/l

—

Dental caries 2

172

1.05

0.04

1.2

1.1

1.90

2.96

u/l

—

Other retinal disorders

117

0.96

0.00

1.0

1.1

—

3.11

—

Hernia

177

1.00

0.00

1.1

1.63

3.04

u/l

—

Dental caries 2 and operation codes

171

1.02

0.00

1.1

1.90

3.03

u/l

—

Dental caries 2 and operation codes, only avohilmo

127

1.03

0.00

1.1

1.0

2.02

2.27

u/l

—

Benign neoplasm: Liver

0.00

0.0

1.0

—

Acute poliomyelitis

0.00

0.0

1.0

—

Hepatocellular carcinoma

0.00

0.0

1.0

—

Malignant neoplasm of other connective and soft tissue

0.00

0.0

1.0

—

Exposure to other and unspecified animate mechanical forces

0.00

0.0

1.0

—

Pedestrian injured in collision with car, pick-up truck or van

0.00

0.0

1.0

—

Benign neoplasm: Liver

0.00

0.0

1.0

—

Benign neoplasm: other/unspecified salivary gland

0.00

0.0

1.0

—

Effects of other external causes

0.00

0.0

1.0

—

Premature separation of placenta [abruptio placentae]

0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

0.0

1.0

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

0.0

1.0

—

Fourth [trochlear] nerve palsy

0.00

0.0

1.0

—

Viral agents as the cause of diseases classified to other chapters

0.00

0.0

1.0

—

Chronic Coagulation defects

0.00

0.0

1.0

—

Anxious personality disorder

0.00

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: Liver/bile ducts

0.00

0.0

1.0

—

Maternal care for other known or suspected fetal problems

0.96

0.00

1.2

1.1

—

2.16

—

Chronic mastoiditis

0.00

0.0

1.0

—

Campylobacter enteritis

0.00

0.0

1.0

—

Mild mental retardation

0.00

0.0

1.0

—

Torticollis

0.00

0.0

1.0

—

Other renal tubulo-interstitial diseases

0.00

0.0

1.0

—

Vitamin D deficiency

0.00

0.0

1.0

—

Infection of intervertebral disc (pyogenic)

0.00

0.0

1.0

—

Blood alcohol or alcohol intoxication level

0.00

0.0

1.0

—

Crystal arthropathies, rheuma endpoint

0.00

0.0

1.0

—

Superficial injury of wrist and hand

0.96

0.00

1.0

1.1

—

4.53

—

Sleep disorders

0.89

0.00

1.0

1.1

—

4.19

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.0

1.0

—

Testicular dysfunction

0.00

0.0

1.0

—

Fissure and fistula of anal and rectal regions

0.93

0.00

1.0

1.1

—

4.63

—

Pure hyperglyceridaemia

0.00

0.0

1.0

—

Other crystal arthropathies

0.00

0.0

1.0

—

Melanocytic naevi of scalp and neck

0.00

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.96

0.00

1.1

—

3.86

—

Idiopathic urticaria

0.00

0.0

1.0

—

Disorder of the sleep-wake schedule

0.00

0.0

1.0

—

All dysplastic lesions of the cervix uteri

0.95

0.00

1.0

1.1

—

4.44

—

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Schizoid personality disorder

0.00

0.0

1.0

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.0

—

Superficial injury of neck

0.00

0.0

1.0

—

Benign neoplasm of male genital organs

0.00

0.0

1.0

—

Ulcerative colitis

0.95

0.00

1.0

—

5.16

—

Congenital malformations of great arteries

0.00

0.0

1.0

—

Other and unspecified epidermal thickening

0.00

0.0

1.0

—

Otitis externa

1.00

0.00

1.0

1.1

—

4.80

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.0

1.0

—

Carcinoma in situ of skin of lower limb, including hip

0.00

0.0

1.0

—

Carcinoma in situ of skin of trunk

0.00

0.0

1.0

—

Melanoma in situ of other and unspecified parts of face

0.00

0.0

1.0

—

Benign neoplasm of thyroid gland

0.00

0.0

1.0

—

Melanocytic naevi of scalp and neck

0.00

0.0

1.0

—

Benign neoplasm: Duodenum

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

0.0

1.0

—

Central retinal artery occlusion

0.00

0.0

1.0

—

Benign neoplasm: Liver/bile ducts

0.00

0.0

1.0

—

Benign neoplasm: Skin, unspecified

0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

0.0

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.0

1.0

—

Benign neoplasm: Choroid

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

0.0

1.0

—

Exposure to smoke, fire and flames

0.00

0.0

1.0

—

Toxic effect of alcohol

0.00

0.0

1.0

—

Poisoning by medicine, drug-induced

0.00

0.0

1.0

—

Contusion of toe(s) without damage to nail

0.00

0.0

1.0

—

Post-traumatic wound infection, not elsewhere classified

0.00

0.0

1.0

—

Congenital malformations of breast

0.00

0.0

1.0

—

Congenital deformities of feet

0.00

0.0

1.0

—

Dementia due to Parkinson's disease

0.00

0.0

1.0

—

Congenital deformities of hip

0.00

0.0

1.0

—

Small cell lung cancer, helper endpoint

0.00

0.0

1.0

—

Left hemicolectomy

0.00

0.0

1.0

—

Other interventions on the root canals of the tooth

0.00

0.0

1.0

—

Hydatidiform mole

0.00

0.0

1.0

—

Medical treatment for female infertility

0.91

0.00

1.0

1.1

—

5.24

—

Burn and corrosion of head and neck

0.00

0.0

1.0

—

Burn and corrosion of trunk

0.00

0.0

1.0

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

0.0

1.0

—

Burn and corrosion confined to eye and adnexa

0.00

0.0

1.0

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Complications predominantly related to the puerperium

0.95

0.00

1.0

1.1

—

4.32

—

Bipolar affective disorders

1.00

0.00

1.0

1.1

—

5.59

—

Diabetic retinopathy, excluding more controls

0.94

0.00

1.0

1.1

—

3.55

—

Other disorders of male genital organs

0.00

0.0

1.1

—

Venous complications and haemorrhoids in pregnancy

0.00

0.0

1.0

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

0.0

1.0

—

Parapsoriasis

0.00

0.0

1.0

—

Dyshidrosis [pompholyx]

0.00

0.0

1.0

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

0.0

1.0

—

Schizophrenia or delusion

0.96

0.00

1.1

—

3.86

—

Polycythaemia vera

0.00

0.0

1.0

—

Nonorganic sleeping disorders

0.96

0.00

1.0

1.1

—

4.49

—

Maxillary retrognathism

0.00

0.0

1.0

—

Insulin, fast-acting

0.95

0.00

1.1

—

3.63

u/l

—

Major anomalies of jaw size

0.00

0.0

1.0

—

Mandibular retrognathia AND surgery (BSSRO)

0.00

0.0

1.0

—

Insulin, fast-acting or short human

0.92

0.00

1.1

—

3.54

u/l

—

Rheumatic valve diseases

0.00

0.0

1.0

—

Other intracranial haemorrhages

0.00

0.0

1.0

—

Other melanin hyperpigmentation

0.00

0.0

1.0

—

Other strabismus

1.01

0.00

1.2

1.1

—

4.03

—

Horner syndrome

0.00

0.0

1.0

—

Other degenerative diseases of the basal ganglia

0.00

0.0

1.0

—

Prurigo nodularis

0.00

0.0

1.0

—

Schizotypal disorder

0.00

0.0

1.0

—

Disorders of adult personality and behaviour

1.00

0.00

1.1

—

4.59

—

Testicular hypofunction

0.00

0.0

1.0

—

Acidosis

0.00

0.0

1.0

—

Morphin

0.00

0.0

1.0

—

Charcot foot

0.00

0.0

1.0

—

Carcinoma in situ of skin of lower limb, including hip

0.00

0.0

1.0

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: other/unspecified salivary gland

0.00

0.0

1.0

—

Small cell lung cancer

0.00

0.0

1.0

—

Moderate visual impairment, binocular

0.00

0.0

1.0

—

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Malignant neoplasm of tongue

0.00

0.0

1.0

—

Malignant neoplasm of small intestine

0.00

0.0

1.0

—

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Amputation of thigh

0.00

0.0

1.0

—

Heart failure and hypertrophic cardiomyopathy

0.00

0.0

1.0

—

Cardiomyopathy, Hypertrophic obstructive

0.00

0.0

1.0

—

Viral conjunctivitis

0.00

0.0

1.0

—

Amputation of foot

0.00

0.0

1.0

—

Amputation of ankle bones

0.00

0.0

1.0

—

Syphilis

0.00

0.0

1.0

—

Juvenile rheumatoid arthirtis

0.00

0.0

1.0

—

Malignant neoplasm of larynx

0.00

-0.00

0.0

1.0

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS